Status:

COMPLETED

Emotion Regulation and Emotion Perception

Lead Sponsor:

Duke University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Mind and Life Institute, Hadley, Massachusetts

Conditions:

Emotions

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.

Detailed Description

Decision to close enrollment was made on January 2, 2020.

Eligibility Criteria

Inclusion

  • ages 18-55;
  • have a smartphone and agree to receive text-messages;
  • have difficulty with their relationships or social interactions;
  • high emotion dysregulation, assessed with the Difficulties with Emotion Regulation Scale (DERS)(Gratz \& Roemer, 2004) with scores over 90.

Exclusion

  • Current mania;
  • Meets full criteria for any current psychotic disorder;
  • Currently/chronically homeless;
  • Current suicidal ideation;
  • Psychiatric hospitalization within past 6 months;
  • Unable to read, blind or deaf. Our previous study recruited only participants who were currently in treatment, but this study will include both participants who are currently in treatment, as well as those who are not in treatment.
  • high self-reported autistic traits, as assessed by the Autism Spectrum Quotient (Auyeung \& Baron-Cohen, 2012).

Key Trial Info

Start Date :

February 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 2 2019

Estimated Enrollment :

91 Patients enrolled

Trial Details

Trial ID

NCT03790878

Start Date

February 4 2019

End Date

December 2 2019

Last Update

February 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Medical Center

Durham, North Carolina, United States, 27710